Hepato-pancreato-biliary (HPB) diseases affect the liver, pancreas and biliary tract. This branch of medicine is referred to as hepatology. Diseases involving the hepato-pancreato-biliary system are frequently encountered in patients with inflammatory bowel disease, and are common in patients with Crohn’s disease or ulcerative colitis. Cancers of the liver and pancreas are virulent and have an extremely low cure rate. More research is necessary to lead to effective treatments for these diseases.
An HPB research chair at The Ottawa Hospital would focus on hepato-pancreato-biliary issues, conducting research, coordinating, and leading clinical trials, which would include multi-center, national and international trials for these diseases. A chair would facilitate collaboration with other researchers, putting The Ottawa Hospital in the forefront of research and treatment. A chair would be dedicated to the improvement and outcomes of patient-care in all aspects of HPB disease treatment and recovery.
Our vision is to provide the latest knowledge and the highest standard of treatment and care for HPB patients.
How you can help
The Ottawa Hospital Foundation is raising a $3 million endowment for the Vered Family Chair for Hepato-Pancreato-Biliary Research. A fundraising campaign is now in place to continue to work toward the vision ofworld-class care for everyone in our community.
For more information or to offer your support, please contact Tim Kluke, President and CEO of The Ottawa Hospital Foundation, at 613-798-5555, ext. 12760, by email to email@example.com.